Tradestie Institutional Equity Comparison Engine · Market Close Nov 20, 2026

BHST vs ELVA: Which Stock Is the Better Buy Now?

Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.

ELVA Captures Overall Composite Edge (41.0 SELL vs 58.2 HOLD), While BHST Leads 4–2 on Growth & Valuation Pillars

ELVA Overall Winner 6-Pillar Tally: BHST 4 – 2 ELVA Matrix Metrics: BHST 4 – 6 ELVA

As of Nov 20, 2026, Electrovaya Inc. Common Shares (ELVA) captures the overall head-to-head institutional edge over BioHarvest Sciences Inc. (BHST) on higher Unified Composite conviction (41.0/100 SELL vs. 58.2/100 HOLD) after splitting the core matrix 6–4 (led by Valuation Multiples, Profitability & Quality), while BHST wins 4–2 across the 6-pillar growth and valuation breakdown. BHST trades at $1.30 (N/M Forward P/E, -18.0% operating margin) versus ELVA at $3.27 (18.4x Forward P/E, 9.3% operating margin).

  • Composite vs. Pillar Nuance: While BHST currently prints a higher short-term Unified Composite Score (58.2/100 HOLD vs. ELVA 41.0/100 SELL), ELVA captures the overall institutional head-to-head verdict (6–4 matrix metrics and 2–4 across the 6 pillars) due to superior fundamental profitability (9.3% vs. -18.0% operating margin) and revenue trajectory (+3.4% vs. +3.8% YoY).
  • Technical & Structure Timing Caution: BHST is currently in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 37.2); meanwhile ELVA is in a short-term Weinstein Markdown pullback below its falling 50-day moving average and Breakdown options structure phase (RSI 24.8). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

Executive Snapshot Side-by-Side Composite Ratings & Technical Regime

Ask Alpha AI About BHST vs ELVA
BHST NASDAQ
BioHarvest Sciences Inc. Common Stock
Pharmaceutical Preparations
$1.30
-1.52% 1D
Market Cap $29.9M
TTM Revenue $35M
Forward P/E N/M
Beta / 30D Vol 0.25β · 86% Vol
Unified Composite Score
58.2 / 100 HOLD
Tech 75.0 Fund 57.0 Flow 50.0 Mom 60.0
Weinstein Technical Phase Markdown · Sell / avoid
Price below a falling SMA50 (slope -9.1%), weak momentum, RSI 37
RSI-14: 37.2 · SMA20: $1.55 · SMA50: $1.58
ELVA NASDAQ Head-to-Head Winner
Electrovaya Inc. Common Shares
Miscellaneous Electrical Machinery, Equipment & Supplies
$3.27
-11.86% 1D
Market Cap $185.5M
TTM Revenue $72M
Forward P/E 18.4x
Beta / 30D Vol 3.51β · 89% Vol
Unified Composite Score
41.0 / 100 SELL
Tech 25.0 Fund 48.0 Flow 66.0 Mom 59.0
Weinstein Technical Phase Markdown · Sell / avoid
Price below a falling SMA50 (slope -13.2%), weak momentum, RSI 25
RSI-14: 24.8 · SMA20: $4.76 · SMA50: $5.51

6-Pillar Scorecard Institutional Category Breakdown (BHST 4 – 2 ELVA)

Columns: Metric · BHST · ELVA
1. Valuation Multiples ELVA
Forward P/E N/M 18.4x
Trailing P/E N/M 37.1x
PEG Ratio N/M 0.28x
EV / Revenue 0.7x 3.0x
2. Growth & Scale BHST
Revenue Growth (YoY) +3.8% +3.4%
Earnings Growth (YoY) +0.0% -69.3%
TTM Revenue (USD) $35M $72M
Market Cap $29.9M $185.5M
3. Profitability & Quality ELVA
Gross Margin 59.0% 33.0%
Operating Margin -18.0% 9.3%
Net Profit Margin -31.2% 6.1%
Return on Equity (ROE) -142.5% 9.8%
4. Balance Sheet & Cash Flow BHST
Cash Generation (TTM) -$9.4M -$37M
Cash Flow Margin -26.6% -51.1%
Net Cash / Leverage $5.1M Net Cash $28M Net Debt (0.61x D/E)
Dividend Yield None (0.00%) None (0.00%)
5. Options & Positioning BHST
Options Structure Phase UNCLASSIFIED BREAKDOWN
Current IV / %ile N/A (N/A) 88.1% (28th %ile)
Put/Call OI Skew N/A 0.91x (Balanced)
OBV Trend / Tech Phase NEUTRAL · Markdown DISTRIBUTION · Markdown
6. R&D & Supply-Chain Moat BHST
OpEx & R&D Intensity 77.0% of Rev ($27M) 23.7% of Rev ($17M)
90D R&D Disclosures 0 papers 0 papers
Competitive Moat Cyclical / Execution-Driven Positioning Cyclical / Execution-Driven Positioning
Supply-Chain Role Packaged Foods Operator Electrical Equipment & Parts Operator

Core Matrix Head-to-Head Valuation, Margin, Cash Flow & Risk Table

Core Matrix Wins: BHST (4) vs ELVA (6)
Institutional Metric BHST ELVA Criterion Row Edge
Market Capitalization
Scale
$29.9M $185.5M Larger Scale ELVA
Trailing P/E Ratio
Valuation
N/M 37.1x Lower Multiple ELVA
Forward P/E Ratio
Valuation
N/M 18.4x Lower Multiple ELVA
Revenue Growth (YoY)
Growth
+3.8% +3.4% Higher Growth BHST
Operating Margin (TTM)
Profitability
-18.0% 9.3% Higher Margin ELVA
Net Profit Margin
Profitability
-31.2% 6.1% Higher Margin ELVA
Return on Equity (ROE)
Capital Efficiency
-142.5% 9.8% Higher ROE ELVA
52-Week Range Position
Momentum
6% ($1–$7) 0% ($3–$13) Stronger Trend BHST
Beta / 30D Volatility
Risk Regime
0.25β · 86% Vol 3.51β · 89% Vol Lower Realized Risk BHST
Unified Institutional Score
Composite Signal
58.2 / 100 (HOLD) 41.0 / 100 (SELL) Higher Composite BHST
Trailing 12M Revenue (USD)
Operating Scale
$35M $72M FX-Normalized USD Scale
Gross Profit Margin (TTM)
Unit Pricing Power
59.0% 33.0% Higher Margin Quality
PEG Ratio & EV / Revenue
Growth-Adjusted Valuation
N/M PEG · 0.7x EV/Rev 0.28x PEG · 3.0x EV/Rev Lower Multiple Valuation
Cash Flow & Balance Sheet
Capital Self-Funding
-$9.4M ($5.1M Net Cash) -$37M ($28M Net Debt (0.61x D/E)) Higher Cash / Net Cash Solvency

Momentum Normalized Relative Price Performance (1M · 3M · 6M · 1Y)

1M Horizon BHST +14.5 pp
BHST: -22.62% · ELVA: -37.12%
3M Horizon BHST +12.32 pp
BHST: -36.59% · ELVA: -48.91%
6M Horizon BHST +3.62 pp
BHST: -66.32% · ELVA: -69.94%
1Y Horizon ELVA +51.59 pp
BHST: -79.4% · ELVA: -27.81%

Financial Trajectory Annualized Quarterly Run-Rate Revenue & Operating Margin Trajectory (USD-Normalized)

Split-Invariant USD Revenue & Operating Margin (%)
Period BHST Revenue ELVA Revenue BHST Op. Margin ELVA Op. Margin Margin Leader
Q2 '25 $30M $70M -21.3% 11.5% ELVA
Q3 '25 $40M $80M -10.1% 11.7% ELVA
Q4 '25 $40M $60M -12.4% 8.8% ELVA
Q1 '26 $30M $70M -21.6% 12.1% ELVA

Options Positioning Implied Volatility, Put/Call Skew & Dealer Gamma Corridor

Live Options Phase Tracker
BHST UNCLASSIFIED
0d in phase · OBV NEUTRAL
Current IV N/A
IV Percentile N/A
Put/Call OI Skew N/A
IV Regime Unclassified
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow NEUTRAL
Exact BHST Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →
ELVA BREAKDOWN
120d in phase · OBV DISTRIBUTION
Current IV 88.1%
IV Percentile 28th %ile
Put/Call OI Skew 0.91x (Balanced)
IV Regime Balanced (25th–60th %ile)
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal BULLISH
OBV Flow DISTRIBUTION
Exact ELVA Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →

Moat & R&D Supply-Chain Positioning, Bottleneck Moat & R&D Velocity

Corporate R&D & Foundry Leaderboard
BHST Moat Profile Cyclical / Execution-Driven Positioning
Packaged Foods Operator
Competes within the Packaged Foods value chain with $29.9M market capitalization and -18.0% operating margin.
OpEx & R&D Reinvestment 77.0% of Rev ($27M)
90D Engineering Disclosures 0 Published
ELVA Moat Profile Cyclical / Execution-Driven Positioning
Electrical Equipment & Parts Operator
Competes within the Electrical Equipment & Parts value chain with $185.5M market capitalization and 9.3% operating margin.
OpEx & R&D Reinvestment 23.7% of Rev ($17M)
90D Engineering Disclosures 0 Published

Investor FAQ BHST vs ELVA Key Questions & Quantitative Answers

As of Nov 20, 2026, Electrovaya Inc. Common Shares (ELVA) captures the overall head-to-head institutional edge over BioHarvest Sciences Inc. (BHST) on higher Unified Composite conviction (41.0/100 SELL vs. 58.2/100 HOLD) after splitting the core matrix 6–4 (led by Valuation Multiples, Profitability & Quality), while BHST wins 4–2 across the 6-pillar growth and valuation breakdown. BHST trades at $1.30 (N/M Forward P/E, -18.0% operating margin) versus ELVA at $3.27 (18.4x Forward P/E, 9.3% operating margin). Composite vs. Pillar Nuance: While BHST currently prints a higher short-term Unified Composite Score (58.2/100 HOLD vs. ELVA 41.0/100 SELL), ELVA captures the overall institutional head-to-head verdict (6–4 matrix metrics and 2–4 across the 6 pillars) due to superior fundamental profitability (9.3% vs. -18.0% operating margin) and revenue trajectory (+3.4% vs. +3.8% YoY). Technical & Structure Timing Caution: BHST is currently in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 37.2); meanwhile ELVA is in a short-term Weinstein Markdown pullback below its falling 50-day moving average and Breakdown options structure phase (RSI 24.8). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

BHST leads the Growth & Scale pillar: BHST posts +3.8% YoY revenue growth and +0.0% YoY earnings growth on $35M TTM revenue (59.0% gross margin, -18.0% operating margin), compared with ELVA at +3.4% YoY revenue growth and -69.3% YoY earnings growth on $72M TTM revenue (33.0% gross margin, 9.3% operating margin). Across the 4-period historical trajectory (Q2 '25 to Q1 '26), BHST cumulative revenue shifted +0.0% while ELVA shifted +0.0%. In operating R&D and SG&A reinvestment, BHST deploys 77.0% of Rev ($27M) (0 90-day corporate R&D disclosures) versus 23.7% of Rev ($17M) (0 disclosures) for ELVA.

ELVA screens cheaper on headline valuation multiples. BHST trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and 0.7x EV/Revenue (-26.6% FCF margin), whereas ELVA trades at 18.4x Forward P/E, 37.1x Trailing P/E, 0.28x PEG, and 3.0x EV/Revenue (-51.1% FCF margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against BHST (-142.5% ROE) versus ELVA (9.8% ROE) capital efficiency.

In options market volatility and institutional positioning, BHST carries N/A implied volatility (N/A, Unclassified), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (0.25β · 86% Vol realized risk). By comparison, ELVA carries 88.1% implied volatility (28th %ile, Balanced (25th–60th %ile)), a 0.91x (Balanced) Put/Call open-interest ratio, DISTRIBUTION on-balance volume, and sits in a BREAKDOWN options structure phase (3.51β · 89% Vol realized risk).

Cross-Compare 1-Click Peer Rivalries & Single-Stock Research

Launch Custom Ticker Comparison →

Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 20, 2026. For educational research only; not investment advice.